Lomustine (CCNU) is a chemotherapy drug used to treat various cancers, mainly brain tumors (primary and metastatic) and Hodgkin’s lymphoma, often after other treatments have failed or as part of combination therapy. It’s an alkylating agent that stops cancer cell growth by damaging their DNA, and it’s taken orally in capsules. Due to its potency, it requires careful monitoring for serious side effects like bone marrow suppression (low blood counts) and lung damage. It is grouped under the following drug class(es): Alkylating agents, Antineoplastic agents and Cytotoxics. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Belustine and Cecenu. Its PubChem CID is 3950.
Lomustine
| CAS No | 13010-47-4 |
|---|---|
| Molecular Formula | C9H16ClN3O2 |
| Molecular Weight | 233.69 g/mol |
| Synonyms | 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lomustine (CCNU) is a chemotherapy drug used to treat various cancers, mainly brain tumors (primary and metastatic) and Hodgkin's lymphoma, often after other treatments have failed or as part of combination therapy.
The listed CAS number is 13010-47-4.
The listed molecular formula is C9H16ClN3O2.
The listed molecular weight is 233.69 g/mol.
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
The source lists Belustine and Cecenu.